Summary & Overview
HCPCS K1029: Oral Tongue Neuromuscular Stimulation Device, 90-Day
HCPCS Level II code K1029 designates an oral appliance used for neuromuscular electrical stimulation of the tongue muscle, supplied as a 90-day kit and intended to be used with a separate power source and phone-controlled electronics unit. This code matters nationally as use of app-controlled neuromuscular devices for oropharyngeal and swallowing disorders is growing, raising coverage, coding, and supply considerations across payers. Major payers in this review include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of what K1029 represents, typical sites of service and service type, and the clinical context for device use. The publication summarizes payer coverage patterns where available, coding and billing considerations tied to device kits and durable medical equipment billing, and relevant clinical context about neuromuscular tongue stimulation. When specific data elements were not provided in the input, the report indicates "Data not available in the input."
Billing Code Overview
HCPCS Level II code K1029 describes an oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, supplied as a 90-day kit and intended for use with a separate power source and control electronics unit that is controlled via a phone application. This device is used to deliver neuromuscular electrical stimulation to the tongue musculature.
-
Service type: Durable medical equipment / assistive oral neuromuscular stimulation device
-
Typical site of service: Outpatient clinics, home settings, and durable medical equipment suppliers where patients use the device with a compatible power/control unit and smartphone application
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with moderate-to-severe obstructive sleep apnea (OSA) or chronic dysphagia with documented tongue base weakness who has not achieved adequate response to conservative therapies (continuous positive airway pressure, oral appliance therapy, or swallow therapy). The device described by K1029 is an intraoral neuromuscular electrical stimulation (NMES) appliance used together with a separate power/control unit and a phone application; a 90-day supply is supplied for a course of home-based therapy.
Clinical workflow:
-
Initial evaluation by a sleep medicine specialist, otolaryngologist, or speech-language pathologist (SLP) documenting diagnosis, prior treatments, and indication for tongue-targeted NMES.
-
Baseline testing as indicated: overnight polysomnography for OSA or instrumental swallow assessment (videofluoroscopic swallow study or fiberoptic endoscopic evaluation of swallowing) for dysphagia.
-
Device fitting and patient education visit with the prescribing clinician or trained SLP: intraoral appliance placement, demonstration of handset/phone application controls, wearing schedule, skin/oral hygiene, and safety precautions.
-
Remote or in‑person follow-up at 2–6 weeks to assess tolerance, adherence data from the phone app, symptom response, and to adjust usage parameters via the control unit.
-
Outcome assessment at approximately 90 days with objective or functional reassessment (repeat sleep study or swallow assessment as clinically indicated) and documentation of benefit or lack thereof for ongoing coverage decisions.
Typical site of service: outpatient clinic (sleep medicine or otolaryngology), specialty device clinic, or speech-language pathology practice; device is used primarily in the home setting under clinician supervision.